Lansforsakringar Fondforvaltning’s Eli Lilly LLY Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$290M	Buy	315,757 +1,981	+0.6%	+$2.01M	1.52%	11
2025 Q4	$337M	Buy	313,776 +2,815	+0.9%	+$2.69M	1.67%	10
2025 Q3	$237M	Sell	310,961 -494	-0.2%	-$368K	1.23%	12
2025 Q2	$243M	Sell	311,455 -34,969	-10%	-$27.2M	1.39%	12
2025 Q1	$286M	Sell	346,424 -4,148	-1%	-$3.45M	1.76%	7
2024 Q4	$271M	Buy	+350,572	New	+$290M	1.51%	10

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lansforsakringar Fondforvaltning's LLY Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning increased its Eli Lilly (LLY) stake by 0.63% in Q1 2026, buying an estimated $2.01M and bringing the position to 315,757 shares worth $290M. The position accounts for 1.52% of the portfolio, ranked #11.

Lansforsakringar Fondforvaltning first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $337M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Lansforsakringar Fondforvaltning held 315,757 shares of Eli Lilly worth $290M as of Q1 2026.
Lansforsakringar Fondforvaltning bought 1,981 Eli Lilly shares in Q1 2026, an estimated $2.01M.
Eli Lilly made up 1.52% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #11 holding.
Lansforsakringar Fondforvaltning first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
Lansforsakringar Fondforvaltning's Eli Lilly position peaked at $337M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.